- Home
- PPBT vs HOTH Comparison
PPBT vs HOTH Comparison
Compare PPBT & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- HOTH
- Stock Information
- Founded
- PPBT 2010
- HOTH 2017
- Country
- PPBT Israel
- HOTH United States
- Employees
- PPBT N/A
- HOTH N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- PPBT Health Care
- HOTH Health Care
- Exchange
- PPBT Nasdaq
- HOTH Nasdaq
- Market Cap
- PPBT 9.2M
- HOTH 7.6M
- IPO Year
- PPBT N/A
- HOTH 2019
- Fundamental
- Price
- PPBT $2.51
- HOTH $0.82
- Analyst Decision
- PPBT Strong Buy
- HOTH Strong Buy
- Analyst Count
- PPBT 2
- HOTH 4
- Target Price
- PPBT $126.50
- HOTH $4.75
- AVG Volume (30 Days)
- PPBT 61.9K
- HOTH 996.3K
- Earning Date
- PPBT 11-15-2024
- HOTH 11-12-2024
- Dividend Yield
- PPBT N/A
- HOTH N/A
- EPS Growth
- PPBT N/A
- HOTH N/A
- EPS
- PPBT N/A
- HOTH N/A
- Revenue
- PPBT N/A
- HOTH N/A
- Revenue This Year
- PPBT N/A
- HOTH N/A
- Revenue Next Year
- PPBT N/A
- HOTH N/A
- P/E Ratio
- PPBT N/A
- HOTH N/A
- Revenue Growth
- PPBT N/A
- HOTH N/A
- 52 Week Low
- PPBT $2.45
- HOTH $0.58
- 52 Week High
- PPBT $23.20
- HOTH $1.73
- Technical
- Relative Strength Index (RSI)
- PPBT 28.04
- HOTH 42.93
- Support Level
- PPBT $2.50
- HOTH $0.83
- Resistance Level
- PPBT $2.82
- HOTH $0.90
- Average True Range (ATR)
- PPBT 0.38
- HOTH 0.09
- MACD
- PPBT 0.04
- HOTH -0.01
- Stochastic Oscillator
- PPBT 5.10
- HOTH 10.18
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.